{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:20:29Z","timestamp":1794007229631,"version":"4.8.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neurol.2022.11.004","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T15:53:48Z","timestamp":1673970828000},"page":"265-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review"],"prefix":"10.1016","volume":"179","author":[{"given":"O.","family":"Mirmosayyeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Ghaffary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pourkazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0515","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis\u00a0\u2013\u00a0a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2022.11.004_bib0520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1474-4422(03)00663-X","article-title":"Genetics of multiple sclerosis","volume":"3","author":"Dyment","year":"2004","journal-title":"Lancet Neurol"},{"issue":"17","key":"10.1016\/j.neurol.2022.11.004_bib0525","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","article-title":"Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG\u2013positive NMOSD","volume":"91","author":"Shosha","year":"2018","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.neurol.2022.11.004_bib0530","doi-asserted-by":"crossref","first-page":"e1645","DOI":"10.1212\/WNL.0000000000009245","article-title":"Evaluation of efficacy and tolerability of first-line therapies in NMOSD","volume":"94","author":"Poupart","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.004_bib0535","doi-asserted-by":"crossref","first-page":"100690","DOI":"10.1016\/j.cegh.2020.100690","article-title":"Spatial mapping of COVID-19 for Indian states using principal component analysis","volume":"10","author":"Joshua","year":"2021","journal-title":"Clin Epidemiol Glob Heal"},{"key":"10.1016\/j.neurol.2022.11.004_bib0540","unstructured":"COVID-19 CORONAVIRUS PANDEMIC. Worldometer. 2021."},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4081\/idr.2020.8543","article-title":"National institute for the infectious diseases \u201cL. Spallanzani\u201d IRCCS. Recommendations for COVID-19 clinical management","volume":"12","author":"Nicastri","year":"2020","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.neurol.2022.11.004_bib0550","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbi.2020.05.037","article-title":"Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection","volume":"88","author":"Liguori","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.neurol.2022.11.004_bib0555","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0560","doi-asserted-by":"crossref","first-page":"116969","DOI":"10.1016\/j.jns.2020.116969","article-title":"Neurological manifestations and COVID-19: experiences from a tertiary care center at the frontline","volume":"415","author":"Pinna","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.004_bib0565","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s42399-020-00315-y","article-title":"Clinical features of COVID-19 in a young man with massive cerebral hemorrhage\u00a0\u2014\u00a0case report","volume":"2","author":"Bao","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"7","key":"10.1016\/j.neurol.2022.11.004_bib0570","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3174\/ajnr.A6595","article-title":"Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection","volume":"41","author":"Franceschi","year":"2020","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116945","article-title":"COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy","volume":"415","author":"Radmanesh","year":"2020","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0580","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11239-020-02228-y","article-title":"COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature","volume":"50","author":"Tan","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.neurol.2022.11.004_bib0585","doi-asserted-by":"crossref","first-page":"100136","DOI":"10.1016\/j.bbih.2020.100136","article-title":"Acute encephalopathy is associated with worse outcomes in COVID-19 patients","volume":"8","author":"Shah","year":"2020","journal-title":"Brain Behav Immunity-Health"},{"issue":"2","key":"10.1016\/j.neurol.2022.11.004_bib0590","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s13365-021-00957-1","article-title":"Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia","volume":"27","author":"Shahali","year":"2021","journal-title":"J Neurovirol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0595","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.1016\/j.inat.2021.101320","article-title":"Optic neuritis post-COVID-19 infection. A case report with meta-analysis","volume":"26","author":"Azab","year":"2021","journal-title":"Interdiscip Neurosurg"},{"key":"10.1016\/j.neurol.2022.11.004_bib0600","doi-asserted-by":"crossref","first-page":"102377","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following SARS-CoV-2 infection","volume":"45","author":"Palao","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2022.11.004_bib0605","doi-asserted-by":"crossref","first-page":"102474","DOI":"10.1016\/j.msard.2020.102474","article-title":"Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: a case report","volume":"46","author":"de Ruijter","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2022.11.004_bib0610","first-page":"1","article-title":"Assessing the consequences of quarantines during a pandemic","volume":"22","author":"Forslid","year":"2021","journal-title":"Eur J Heal Econ"},{"issue":"11","key":"10.1016\/j.neurol.2022.11.004_bib0615","first-page":"23","article-title":"Psychological effects of the Coronavirus disease-2019 pandemic","volume":"7","author":"Sood","year":"2020","journal-title":"Res Humanit Med Educ"},{"key":"10.1016\/j.neurol.2022.11.004_bib0620","volume":"31","author":"Suarez-Gonzalez","year":"2020"},{"key":"10.1016\/j.neurol.2022.11.004_bib0625","series-title":"Effects of the quarantines and activity restrictions related to the coronavirus disease (COVID-19) on air quality in Latin America's cities","author":"Cepal","year":"2020"},{"key":"10.1016\/j.neurol.2022.11.004_bib0630","series-title":"Effects of corona virus on the world community","author":"Khan","year":"2020"},{"issue":"5","key":"10.1016\/j.neurol.2022.11.004_bib0635","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/pathogens9050324","article-title":"Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment","volume":"9","author":"Koyama","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.neurol.2022.11.004_bib0640","series-title":"BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study","author":"Pfizer","year":"2020"},{"issue":"11","key":"10.1016\/j.neurol.2022.11.004_bib0645","doi-asserted-by":"crossref","first-page":"396","DOI":"10.15585\/mmwr.mm7011e3","article-title":"Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks\u2014Connecticut, December 2020\u2013February 2021","volume":"70","author":"Britton","year":"2021","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0650","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jmv.27293","article-title":"Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease","volume":"94","author":"Zawbaa","year":"2022","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.neurol.2022.11.004_bib0655","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.immuni.2021.06.017","article-title":"COVID-19 vaccine access in Africa: global distribution, vaccine platforms, and challenges ahead","volume":"54","author":"Loemb\u00e9","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.neurol.2022.11.004_bib0660","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eprac.2021.01.013","article-title":"COVID-19 vaccine","volume":"27","author":"Fernandes","year":"2021","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0665","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/life11030249","article-title":"Self-reported real-world safety and reactogenicity of covid-19 vaccines: a vaccine recipient survey","volume":"11","author":"Mathioudakis","year":"2021","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0670","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: a case series","volume":"269","author":"Khayat-Khoei","year":"2022","journal-title":"J Neurol [Internet]"},{"key":"10.1016\/j.neurol.2022.11.004_bib0675","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","article-title":"Effects of COVID-19 on the nervous system","volume":"183","author":"Iadecola","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2022.11.004_bib0680","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1016\/j.radcr.2021.09.033","article-title":"Post COVID-19 vaccination neuromyelitis optica spectrum disorder: case report & MRI findings","volume":"16","author":"Badrawi","year":"2021","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.neurol.2022.11.004_bib0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577755","article-title":"Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine","volume":"361","author":"Fujimori","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0690","series-title":"JBI critical appraisal checklist for case reports","author":"Institute","year":"2017"},{"issue":"6","key":"10.1016\/j.neurol.2022.11.004_bib0905","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/20009666.2021.1979745","article-title":"A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine","volume":"11","author":"Tagliaferri","year":"2021","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.neurol.2022.11.004_bib0765","first-page":"e17961","article-title":"Neuromyelitis optica in a healthy female after severe acute respiratory syndrome Coronavirus 2 mRNA-1273 vaccine","volume":"13","author":"Fujikawa","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib1005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","article-title":"First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine","volume":"269","author":"Havla","year":"2021","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2022.11.004_bib1010","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mrna\/dna SARS-Cov-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.neurol.2022.11.004_bib0770","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s10072-021-05427-4","article-title":"Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19","volume":"42","author":"Chen","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.004_bib1015","doi-asserted-by":"crossref","first-page":"100006","DOI":"10.1016\/j.nerep.2021.100006","article-title":"COVID-19 vaccine (ChAdOx1 nCoV-19 Corona virus vaccine (Recombinant)\u00a0\u2013\u00a0COVISHIELD related MS relapse","volume":"1","author":"Mathew","year":"2021","journal-title":"Neuroimmunol Reports"},{"key":"10.1016\/j.neurol.2022.11.004_bib1020","first-page":"362","article-title":"New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure","author":"Toljan","year":"2022","journal-title":"J Neuroimmunol [Internet]"},{"key":"10.1016\/j.neurol.2022.11.004_bib0760","article-title":"Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: case report and systematic review","volume":"58","author":"Anamnart","year":"2022","journal-title":"Mult Scler Relat Disord [Internet]"},{"key":"10.1016\/j.neurol.2022.11.004_bib0775","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/NRL.0000000000000420","article-title":"A case with new-onset neuromyelitis optica spectrum disorder following COVID-19 mRNA BNT162b2 vaccination","volume":"27","author":"Caliskan","year":"2022","journal-title":"Neurologist"},{"issue":"S1","key":"10.1016\/j.neurol.2022.11.004_bib0695","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1017\/S003118200001698X","article-title":"parasites and immune responses","volume":"122","author":"Cox","year":"2001","journal-title":"Parasitology"},{"issue":"7\u20138","key":"10.1016\/j.neurol.2022.11.004_bib0700","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0264-410X(02)00574-1","article-title":"Induction of immune responses by DNA vaccines in large animals","volume":"21","author":"Babiuk","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.neurol.2022.11.004_bib0705","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-108-2-221","article-title":"Varicella-zoster virus infections: biology, natural history, treatment, and prevention","volume":"108","author":"Straus","year":"1988","journal-title":"Ann Intern Med"},{"issue":"34","key":"10.1016\/j.neurol.2022.11.004_bib0710","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0715","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/end.2000.14.5","article-title":"A short history of the Foley catheter: from handmade instrument to infection-prevention device","volume":"14","author":"Carr","year":"2000","journal-title":"J Endourol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0720","first-page":"76","article-title":"History of infection prevention and control","volume":"76","author":"Torriani","year":"2010","journal-title":"Infect Dis (Auckl)"},{"issue":"12","key":"10.1016\/j.neurol.2022.11.004_bib0725","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2022.11.004_bib0730","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.90.9.4156","article-title":"Gene inoculation generates immune responses against human immunodeficiency virus type 1","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neurol.2022.11.004_bib0735","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.897275","article-title":"Case report: exacerbation of relapses following mRNA COVID-19 vaccination in multiple sclerosis: a case series","volume":"13","author":"Quintanilla-Bord\u00e1s","year":"2022","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0740","first-page":"75","article-title":"Role of toll-like receptors in multiple sclerosis","volume":"2","author":"Miranda-Hernandez","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.neurol.2022.11.004_bib0745","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell\u2013mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2022.11.004_bib0750","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"10.1016\/j.neurol.2022.11.004_bib0755","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/00207454.2016.1163550","article-title":"Th17 cells in neuromyelitis optica spectrum disorder: a review","volume":"126","author":"Lin","year":"2016","journal-title":"Int J Neurosci"},{"issue":"10","key":"10.1016\/j.neurol.2022.11.004_bib0780","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/ph14101049","article-title":"Side effects of mRNA-based COVID-19 vaccines among young adults (18\u201330-years-old): an independent post-marketing study","volume":"14","author":"Riad","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neurol.2022.11.004_bib0785","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study","volume":"14","author":"El-Shitany","year":"2021","journal-title":"Int J Gen Med"},{"issue":"7","key":"10.1016\/j.neurol.2022.11.004_bib0790","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.neurol.2022.11.004_bib0795","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1726-4901(09)70435-6","article-title":"Optic neuritis following hepatitis B vaccination in a 9-year-old girl","volume":"72","author":"Erguven","year":"2009","journal-title":"J Chinese Med Assoc"},{"issue":"10","key":"10.1016\/j.neurol.2022.11.004_bib0800","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/s-2001-18392","article-title":"Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever","volume":"218","author":"Voigt","year":"2001","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"10.1016\/j.neurol.2022.11.004_bib0805","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12250-014-3516-9","article-title":"Varicella zoster virus vaccines: potential complications and possible improvements","volume":"29","author":"Silver","year":"2014","journal-title":"Virol Sin"},{"key":"10.1016\/j.neurol.2022.11.004_bib0810","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-540-92165-3_3","article-title":"Seasonal influenza vaccines","volume":"333","author":"Fiore","year":"2009","journal-title":"Vaccines pandemic Influ"},{"issue":"46","key":"10.1016\/j.neurol.2022.11.004_bib0815","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1016\/j.vaccine.2011.08.093","article-title":"Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination","volume":"29","author":"Williams","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.neurol.2022.11.004_bib0820","first-page":"150","article-title":"Neurological complications of rabies vaccines","volume":"40","author":"Tullu","year":"2003","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.neurol.2022.11.004_bib0825","doi-asserted-by":"crossref","first-page":"102712","DOI":"10.1016\/j.jaut.2021.102712","article-title":"Thrombocytopenia after COVID-19 vaccination","volume":"123","author":"Kragholm","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.neurol.2022.11.004_bib0830","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.metop.2021.100145","article-title":"Serious complications of COVID-19 vaccines: a mini-review","volume":"12","author":"Fragkou","year":"2021","journal-title":"Metab Open"},{"issue":"10","key":"10.1016\/j.neurol.2022.11.004_bib0835","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamacardio.2021.2821","article-title":"Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines","volume":"6","author":"Shay","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0840","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2021.06.047","article-title":"Acute myocardial infarction within 24hours after COVID-19 vaccination","volume":"156","author":"Sung","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0845","first-page":"1","article-title":"Acute myocardial infarction and myocarditis following COVID-19 vaccination","author":"Aye","year":"2021","journal-title":"QJM An Int J Med"},{"issue":"2","key":"10.1016\/j.neurol.2022.11.004_bib0850","article-title":"Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0855","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.27251","article-title":"Post COVID-19 vaccine small fiber neuropathy","volume":"64","author":"Waheed","year":"2021","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.neurol.2022.11.004_bib0860","article-title":"Two cases of post-Moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus","volume":"13","author":"Liu","year":"2021","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.neurol.2022.11.004_bib0865","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/medicina57101010","article-title":"Acute transverse myelitis after COVID-19 vaccination","volume":"57","author":"Hsiao","year":"2021","journal-title":"Medicina (B Aires)"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0870","first-page":"1","article-title":"Spectrum of neurological complications following COVID-19 vaccination","volume":"43","author":"Garg","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.004_bib0875","doi-asserted-by":"crossref","first-page":"108136","DOI":"10.1016\/j.intimp.2021.108136","article-title":"Adverse events occurring post-covid-19 vaccination among healthcare professionals\u00a0\u2013\u00a0a mixed method study","volume":"100","author":"Mahapatra","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1016\/j.neurol.2022.11.004_bib0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1971920","article-title":"Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report","volume":"17","author":"Mirmosayyeb","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.neurol.2022.11.004_bib0885","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.4103\/ijo.IJO_1658_21","article-title":"Facial nerve palsy after COVID-19 vaccination\u00a0\u2013\u00a0a rare association or a coincidence","volume":"69","author":"Ish","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0890","doi-asserted-by":"crossref","first-page":"117607","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.neurol.2022.11.004_bib0895","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ggi.14163","article-title":"Delirium triggered by COVID-19 vaccine in an elderly patient","volume":"21","author":"Zavala-Jonguitud","year":"2021","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.neurol.2022.11.004_bib0900","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211051933","article-title":"A case of COVID-19 vaccine associated new diagnosis myasthenia gravis","volume":"12","author":"Chavez","year":"2021","journal-title":"J Prim Care Community Health"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0910","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12028-020-00978-4","article-title":"Neurological implications of COVID-19 infections","volume":"32","author":"Needham","year":"2020","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0915","article-title":"Neurological complications of coronavirus disease (COVID-19): encephalopathy","volume":"12","author":"Filatov","year":"2020","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.neurol.2022.11.004_bib0920","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ajem.2020.05.024","article-title":"Neurologic complications of COVID-19","volume":"38","author":"Bridwell","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.neurol.2022.11.004_bib0925","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000508991","article-title":"COVID-19 infection and neurological complications: present findings and future predictions","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0930","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1017\/cjn.2020.146","article-title":"Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis","volume":"48","author":"Collantes","year":"2021","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"10.1016\/j.neurol.2022.11.004_bib0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105549","article-title":"Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors: stroke and COVID-19","volume":"30","author":"Siow","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2022.11.004_bib0940","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2022.11.004_bib0945","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2009.01.006","article-title":"Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis","volume":"208","author":"Massa","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.neurol.2022.11.004_bib0950","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0955","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/vaccines8010050","article-title":"Infections, vaccines and autoimmunity: a multiple sclerosis perspective","volume":"8","author":"Jakimovski","year":"2020","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.neurol.2022.11.004_bib0960","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3201\/eid2407.161783","article-title":"Registry cohort study to determine risk for multiple sclerosis after vaccination for pandemic influenza A (H1N1) with Arepanrix, Manitoba, Canada","volume":"24","author":"Mahmud","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.neurol.2022.11.004_bib0965","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00415-011-5944-x","article-title":"Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination","volume":"258","author":"McNicholas","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0970","article-title":"Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases","volume":"3679","author":"Vojdani","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2022.11.004_bib0975","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","article-title":"Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?","volume":"60","author":"Talotta","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"10.1016\/j.neurol.2022.11.004_bib0980","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neurol.2022.11.004_bib0985","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2022.11.004_bib0990","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5009450","article-title":"Is myasthenia gravis a real complication of the COVID-19 vaccine? A case report-based systematic review","volume":"2022","author":"Mirmosayyeb","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"10.1016\/j.neurol.2022.11.004_bib0995","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2005.11.005","article-title":"signaling in vaccination","volume":"27","author":"Van Duin","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.neurol.2022.11.004_bib1000","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.msard.2019.06.018","article-title":"TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders","volume":"34","author":"Dias","year":"2019","journal-title":"Mult Scler Relat Disord"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722008256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722008256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:46:59Z","timestamp":1758520019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378722008256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0035378722008256"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.11.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}